Bong-sook Baek

Array ( [id] => 6446463 [patent_doc_number] => 20100279959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors' [patent_app_type] => utility [patent_app_number] => 12/814028 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12972 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279959.pdf [firstpage_image] =>[orig_patent_app_number] => 12814028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993508 [patent_doc_number] => 20110015161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'PHARMACEUTICAL CONTAINING A HOROMONE COMBINATION HAVING A CONTRACEPTIVE EFFECR AND AN INSULIN SENSITIZER' [patent_app_type] => utility [patent_app_number] => 12/793152 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2906 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015161.pdf [firstpage_image] =>[orig_patent_app_number] => 12793152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236426 [patent_doc_number] => 20100267700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 12/785683 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17470 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267700.pdf [firstpage_image] =>[orig_patent_app_number] => 12785683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574190 [patent_doc_number] => 20110269846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Formulations with high percentage cis-p-menthan-7-ol and preparation thereof' [patent_app_type] => utility [patent_app_number] => 12/799682 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269846.pdf [firstpage_image] =>[orig_patent_app_number] => 12799682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355397 [patent_doc_number] => 08673930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Pyrimidylaminobenzamide derivatives for systemic mastocytosis' [patent_app_type] => utility [patent_app_number] => 12/769734 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6143 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12769734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234998 [patent_doc_number] => 20100266702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Particles containing an active agent in the form of a co-precipitate' [patent_app_type] => utility [patent_app_number] => 12/662370 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4077 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266702.pdf [firstpage_image] =>[orig_patent_app_number] => 12662370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784777 [patent_doc_number] => 20120046333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'Methods and Compositions of PI-3 Kinase Inhibitors for Treating Fibrosis' [patent_app_type] => utility [patent_app_number] => 13/262906 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19901 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046333.pdf [firstpage_image] =>[orig_patent_app_number] => 13262906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9440972 [patent_doc_number] => 08710083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Pyridylphenyl compounds for inflammation and immune-related uses' [patent_app_type] => utility [patent_app_number] => 12/749317 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25683 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12749317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401763 [patent_doc_number] => 20100179171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'Pharmacological Treatment of Parkinson\'s Disease' [patent_app_type] => utility [patent_app_number] => 12/730972 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8344 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179171.pdf [firstpage_image] =>[orig_patent_app_number] => 12730972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8944082 [patent_doc_number] => 08497261 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => '3-aminocaprolactam compounds for treating inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 12/726311 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8356 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12726311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336096 [patent_doc_number] => 20120202793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'RHO KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/255879 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 69744 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8733845 [patent_doc_number] => 20130079414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'ENHANCED BIMATOPROST OPHTHALMIC SOLUTION' [patent_app_type] => utility [patent_app_number] => 13/254543 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4361 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296065 [patent_doc_number] => 20100160353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'PHARMACEUTICAL COMPOSITION AND BEVERAGE COMPOSITION COMPRISING L-ARGININE' [patent_app_type] => utility [patent_app_number] => 12/714731 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4954 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160353.pdf [firstpage_image] =>[orig_patent_app_number] => 12714731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7767928 [patent_doc_number] => 20120035140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'CARBAMOYLPHOSPHONATES AS INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/148421 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20265 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035140.pdf [firstpage_image] =>[orig_patent_app_number] => 13148421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6632309 [patent_doc_number] => 20100311835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'CIS-9, TRANS-11 ISOMER OF CONJUGATED LINOLEIC ACID (CLA) FOR TREATING INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/701971 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3993 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311835.pdf [firstpage_image] =>[orig_patent_app_number] => 12701971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343750 [patent_doc_number] => 20100330129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Gastroresistant Pharmaceutical Formulations Containing Rifaximin' [patent_app_type] => utility [patent_app_number] => 12/695945 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6878 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330129.pdf [firstpage_image] =>[orig_patent_app_number] => 12695945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579861 [patent_doc_number] => 20110293744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'BENZOXAZOLE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE' [patent_app_type] => utility [patent_app_number] => 12/689297 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17871 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293744.pdf [firstpage_image] =>[orig_patent_app_number] => 12689297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6322067 [patent_doc_number] => 20100113595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Treatment of neurodegenerative conditions' [patent_app_type] => utility [patent_app_number] => 12/654779 [patent_app_country] => US [patent_app_date] => 2009-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18145 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113595.pdf [firstpage_image] =>[orig_patent_app_number] => 12654779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323352 [patent_doc_number] => 20100113810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Treatment of neurodegenerative conditions' [patent_app_type] => utility [patent_app_number] => 12/654780 [patent_app_country] => US [patent_app_date] => 2009-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18148 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113810.pdf [firstpage_image] =>[orig_patent_app_number] => 12654780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599853 [patent_doc_number] => 07977355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl' [patent_app_type] => utility [patent_app_number] => 12/643202 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7893 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977355.pdf [firstpage_image] =>[orig_patent_app_number] => 12643202 [rel_patent_id] =>[rel_patent_doc_number] =>)